Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;47(3):e214-e221.
doi: 10.1097/CCM.0000000000003631.

Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: Impact of Age on In-Hospital Mortality, Length of Stay, and Costs

Affiliations

Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: Impact of Age on In-Hospital Mortality, Length of Stay, and Costs

Mabel Chung et al. Crit Care Med. 2019 Mar.

Abstract

Objectives: Increasing age is a well-recognized risk factor for in-hospital mortality in patients receiving extracorporeal membrane oxygenation for cardiogenic shock, but the shape of this relationship is unknown. In addition, the impact of age on hospital length of stay, patterns of patient disposition, and costs has been incompletely characterized.

Design: Retrospective analysis of the National Inpatient Sample.

Setting: U.S. nonfederal hospitals, years 2004-2016.

Patients: Adults with cardiogenic shock treated with extracorporeal membrane oxygenation (3,094; weighted national estimate: 15,415).

Interventions: None.

Measurements and main results: The mean age of extracorporeal membrane oxygenation recipients was 54.8 ± 15.4 years (range, 18-90 yr). Crude in-hospital mortality was 57.7%. Median time-to-death was 8 days (interquartile range, 3-17 d). A linear relationship between age and in-hospital mortality was observed with a 14% increase in the adjusted odds of in-hospital mortality for every 10-year increase in age (adjusted odds ratio, 1.14; 95% CI, 1.08-1.21; p < 0.0001). Thirty-four percent of patients were discharged alive at a median time of 30 days (interquartile range, 19-48 d). The median length of stay and total hospitalization costs were 14 days (interquartile range, [5-29 d]) and $134,573 ($71,782-$239,439), respectively, both of which differed significantly by age group (length of stay range from 17 d [18-49 yr] to 9 d [80-90 yr]; p < 0.0001 and cost range $147,548 [18-49 yr] to $105,350 [80-90 yr]; p < 0.0001).

Conclusions: Age is linearly associated with increasing in-hospital mortality in individuals receiving extracorporeal membrane oxygenation for cardiogenic shock without evidence of a threshold effect. Median time-to-death is approximately 1 week. One third of patients are discharged from the hospital alive, but the median time-to-discharge is 1 month. Median length of stay ranges from 9 to 17 days depending on age. Hospitalization costs exceed $100,000 in all age groups.

PubMed Disclaimer

Conflict of interest statement

Copyright form disclosure: Dr. Yeh’s institution received funding from Abiomed, and he has received funding not primarily for the study under consideration from Abiomed Inc, Boston Scientific, Medtronic (consulting), and Abbott Vascular.

Figures

Figure 1:
Figure 1:
Cumulative incidence functions plotting times-to-disposition including time-to-discharge from hospital (i.e. length of stay; black line), time-to-death (long dashed line), time-to-transfer to short-term hospital (short dashed line), time-to-discharge home (self-care and home health care; grey line), and time-to-transfer to skilled nursing facility (dotted line). The “Discharge from Hospital (LOS)” curve represents the summation of patients who have experienced death, transfer, or discharge home; as such, plots of these events illustrate the contributions of these individual components to LOS. At day 14 after admission, which represents the median LOS (vertical grey line), 76.4% (1230/1609) of patients had died, 13.6% (219/1609) had been transferred to a short-term hospital, 6.7% (108/1609) had been discharged home, and 3.1% (50/1609) had been transferred to a skilled nursing facility.
Figure 2:
Figure 2:
In-hospital mortality by age category.

References

    1. Gerke AK, Tang F, Cavanaugh JE, Doerschug KC, Polgreen PM. Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007. BMC Res Notes. 2015;8:686. - PMC - PubMed
    1. Sauer CM, Yuh DD, Bonde P. Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J. 2015;61(1):31–36. - PubMed
    1. McCarthy FH, McDermott KM, Kini V, et al. Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002–2012. Semin Thorac Cardiovasc Surg. 2015;27(2):81–88. - PMC - PubMed
    1. Strom JB, Zhao Y, Shen C, et al. National Trends, Predictors of Use, and In-Hospital Outcomes in the Mechanical Circulatory Support for Cardiogenic Shock EuroIntervention. 2018. - PubMed
    1. Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J. 2017;63(1):60–67. - PubMed

Publication types

MeSH terms

LinkOut - more resources